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A B S T R A C T
Purpose: Little is known about the effect of psychogenic non epileptic seizures (PNES) to caregiver
quality of life (QOL), particularly as it compares to epileptic seizures (ES). We sought to characterize this
effect and identify its determinants.
Methods: The study population comprised of 126 ES and 33 PNES patients who underwent video EEG
monitoring along with 48 and 18 caregivers respectively who accompanied them to their investigations.
Patients completed questionnaires providing demographic, disease-related, cognitive, psychiatric, sleep
and QOL information on admission, prior to their diagnosis being clariﬁed. Their caregivers completed
questionnaires providing demographic, disease burden and generic QOL information. Paraclinical data
were also gathered. Regression analysis was used to identify patient and caregiver related determinants
of patient and caregiver QOL.
Results: QOL scores were signiﬁcantly worse for PNES than ES patients and were mainly linked to
depression levels. PNES and ES caregivers had comparable demographic characteristics and QOL scores.
ES caregiver QOL was better in employed caregivers with lower burden scores for the physical
component summary (PCS) and worse in female caregivers of depressed patients with higher burden
scores for the mental component summary (MCS). Caregiver burden score was the strongest correlate of
PNES caregiver MCS QOL score.
Conclusion: Caregiver QOL in PNES does not differ from caregiver QOL in ES, while patient QOL is worse in
PNES. Caregiver burden emerges as a consistent correlate of caregiver QOL both in ES and PNES. These
ﬁndings advocate for consideration of caregiver burden and QOL in PNES in clinical practice and for
future research paradigms.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Clinical behavior in psychogenic nonepileptic seizures (PNES)
resembles epileptic seizures (ES) without an electrographic correlate
and has a strong psychological basis.1 PNES constitute 10–30% of
referrals to epilepsy specialists,2,3with their prevalence in the general
population being estimated at 2–33 per 100,000,3 generating a
signiﬁcant public health problem with an estimated lifetime cost per
patient cohort year in the US ranging from $110 to 920 million.4* Corresponding author at: Department of Neurology, Emory University School of
Medicine, Faculty Ofﬁce Building at Grady Campus, 49 Jesse Hill Jr. Drive SE, Ofﬁce
335, Atlanta, GA 30303, USA. Tel.: +1 404 616 4013; fax: +1 404 659 0849.
E-mail addresses: ioannis.karakis@emory.edu, yianniskarakis@yahoo.com
(I. Karakis).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.09.011In addition to the society, PNES take a signiﬁcant toll on the
individual patient. Quality of life (QOL) in patients with PNES has
been consistently shown to be worse than in patients with
epileptic seizures (ES).5 Despite their signiﬁcant impact on their
bearers, our understanding of PNES pathophysiology is limited and
hence optimal approach to management remains elusive.6 A
number of interventions have been proposed, which are not
limited to pharmacotherapy, cognitive-behavioral therapy, psy-
chodynamic, psychotherapy, hypnosis and group therapy.7 These
treatments predominantly target the patient,8 typically use seizure
frequency as the primary endpoint,6 have limited generalizability9
and have yielded overall poor outcomes.10,11
More recently, LaFrance et al. elegantly explored the role of
family dysfunction as a potential contributor to poorer QOL in
patients with PNES and subsequently, as a potential foothold forvier Ltd. All rights reserved.
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the caregiver perspective. The primary aims of this study are (i) to
characterize caregiver QOL in PNES and (ii) to identify which
patient and caregiver related factors determine it. As a secondary
aim, we use a comparison group of patients/caregivers with ES and
attempt to ascertain how patient and caregiver characteristics,
QOL scores and QOL determinants differ between the two
populations. We subsequently discuss clinical and research
repercussions of our ﬁndings.
2. Methods
2.1. Participants
The study was approved by the institutional review boards of the
participating hospitals. This cross-sectional study was conducted
between September 2009 and June 2011 at Massachusetts General
Hospital (MGH) and Boston University Medical Center (BUMC).
Adult patients admitted electively to Epilepsy monitoring units at
in those two sites for continuous video-EEG monitoring were asked
to participate by completing a series of questionnaires and
undergoing bed-side cognitive evaluation. Patients who were non
English speakers or unable to read and write due to mental handicap
were excluded. Caregivers who accompanied them were also asked
to complete questionnaires. Caregiver was deﬁned as the family
member who was primarily responsible for providing every-day
care for the patient. After monitoring was completed, patients were
classiﬁed as ES vs PNES based on video-EEG criteria. Only patient
with documented ES (80 at MGH and 46 at BUMC) and PNES (31 at
MGH and 2 at BUMC) along with their respective caregivers (48 for
ES and 18 for PNES, all at MGH) were included in the analysis, while
patients with other non-epileptic seizures (e.g. cardiac arrhythmias,
sleep or movement disorders, etc.), mixed disorder or unclear
diagnosis were excluded along with their caregivers.
2.2. Questionnaires and procedures
Participating patients completed questionnaires providing
demographic (age, gender, race, religion, employment, education,
living situation and marital status) and epilepsy related (age of
disease onset, disease duration, average number of seizures/spells
per month in the past year, number of AED, compliance)
information. Additional information collected was gleaned from
medical records review. Anxiety and depression levels were
measured using the Beck anxiety13 and Beck depression14
inventory respectively. Both have been extensively used previous-
ly in research for ES15 and PNES.12 Sleep quality was assessed by
completing the Epworth sleeping scale16 and the sleep apnea
section of the sleep disorder questionnaire (SDQ-SA).17 While not
speciﬁc to patients with epilepsy, the Epworth sleeping scale has
been widely used to assess sleepiness in a host of diseases
including epilepsy.18 The SDQ-SA has also been commonly applied
to the epilepsy population.19 Quality of life was evaluated by
completing the QOLIE-31 instrument. QOLIE-31 is one of the most
commonly applied QOL instruments in epilepsy with good
reliability and validity.20 It has been previously used for evaluation
of QOL in PNES, given the shared concerns by both groups of
patients, both in this abbreviated form21 as well as in its original
version (QOLIE-89).10 Cognitive evaluation was performed by a
neurologist via administration of the Montreal cognitive assess-
ment (MoCA) test.22 This is a brief screening tool that has been
shown to be superior to the commonly used mini-mental status
examination for the detection of mild cognitive impairment in the
epilepsy population.23 All these evaluations took place on the day
of the admission under electrographic guidance to ensure the
absence of subclinical electrographic seizure activity affectingsome of the responses. At the time of the testing, the patients were
maintained on their home AED(s) and had not been yet sleep
deprived with the intent that their answers would be representa-
tive of their baseline state in the ambulatory setting. They were
also not aware yet of the ﬁnal EMU diagnosis.
Caregivers accompanying the patients also completed ques-
tionnaires prior to establishing the ﬁnal EMU diagnosis. The
questionnaires included several demographic information (age,
gender, race, religion, employment, education, marital status,
cohabitation and time spent for patient care in hours per week).
The latter was loosely deﬁned as the time devoted to everyday
activities were caregiver participation was indispensable including
AED provision, outpatient and emergency department visits and
driving for any patient-related activity. Given the lack of a disease
speciﬁc questionnaire to assess their burden, the Zarit caregiver
burden inventory was used instead. This is a 22-item inventory
derived from the original 29-item inventory.24 It is the most widely
used standardized, validated scale to assess caregiver burden,
administered previously in various neurological disorders, includ-
ing epilepsy.25,26 Caregiver health-related quality of life was
assessed by administering the second version of the SF-36 generic
questionnaire (SF36v2).27 This is a generic QOL instrument that
assesses eight health concepts. Scores standardized to norms and
weighted averages are used to create a summary physical
component summary (PCS) and a mental component summary
(MCS) composed by the ﬁrst and last four of the aforementioned
health concepts respectively. Scores are standardized to norm and
this allows direct comparison among different populations27; thus
it has established precedence in epilepsy caregiver research.
Various paraclinical (laboratory, electroencephalographic and
radiologic) data were collected as part of standard of care. Routine
AED levels were drawn on admission prior to initiation of gradual
withdrawal. For patients on more than one AED, they were deemed
to be supratherapeutic, therapeutic or subtherapeutic on their
regimen depending on the level of the majority of drugs in their
regimen. EEG data pertained to the initial recording during the
completion of the questionnaires (normal, slow, epileptiform)
including the maximal posterior dominant rhythm at the time of
completion and the ﬁnal EMU report for classiﬁcation to the ES vs
PNES category. Radiological data included ﬁndings of the last
patient’s brain magnetic resonance imaging (normal vs abnormal)
obtained before, during or right after this monitoring.
For a detailed description of the questionnaires used both for
patients and caregivers, please refer to the Appendix.
2.3. Analysis
Summary scores were created for all the aforementioned
variables and descriptive statistics were used. Univariate compar-
isons for demographic variables between the ES and PNES patients
and between the ES and PNES caregivers was performed using t-
test (or non-parametric equivalent) for continuous variables
respectively and Chi-square test for categorical variables. The
outcome variable on interest was QOLIE-31 score for ES and PNES
patients and SF-36v2 (PCS and MCS separately) scores for ES and
PNES caregivers. For QOL of ES and PNES patients, only patient
related characteristics were used as covariates. For QOL of ES and
PNES caregivers, both patient and caregiver related characteristics
were used as covariates. Univariate associations between the
outcomes of interest and their potential determinants were
explored by using t-test or one-way ANOVA for categorical
variables and Pearson correlation for continuous variables.
Statistical signiﬁcance was set at 0.05. Those variables identiﬁed
as statistically signiﬁcant in the univariate analysis were
subsequently ﬁtted in a multivariate linear regression model in
order to conduct an adjusted evaluation of QOL determinants.
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confounders (e.g. QOL predictors for PNES caregivers), the results
of the univariate analysis were emphasized instead. Statistical
analysis was performed in SAS (North Carolina).
3. Results
3.1. Patient and caregiver characteristics
ES and PNES patient characteristics are detailed in Table 1a. The
mean age of the patients was 38 years while the mean age for the
caregivers was approximately 42 years. Consistent with previousTable 1
Subject characteristics.
a: Patient characteristics
Epilepsy
Demographic characteristics
Age (mean  SD) 38.20  1
Gender (n, % female) 74 (58.7
Race (n, % caucasian) 103 (83.
Religion (n, % Christian) 75 (75%)
Employment (n, % employed) 68 (55.7
Education (n, % some college and beyond) 85 (75.8
Living situation (n, % living with family or others) 101 (85.
Marital status (n, % married) 51 (40.7
Epilepsy characteristics
Age of onset of epilepsy (mean  SD) 23.84  1
Duration of epilepsy (mean  SD) 14.80  1
Number of seizures/spells per month (median, IQR) 3 (1–8) 
Number of AED (median, IQR) 2 (1–3) 
Compliance (n, % compliant) 95 (77.8
Paraclinical characteristics
AEDs level
Normal 66 (70.2
Low 20 (21.2
High 8 (8.51%
EEG posterior dominant rhythm (mean  SD) 9.40  1.
EEG ﬁndings
Slowing 21 (16.9
Interictal spikes 46 (37.1
Normal 57 (45.9
MRI ﬁndings (n, % abnormal) 83 (69.1
Neuropsychological and sleep characteristics
Montreal cognitive assessment score (MoCA) (median, IQR) 25.32  3
Beck depression inventory (mean  SD) 13.25  1
Beck anxiety inventory (mean  SD) 15.64  1
Epworth sleepiness scale (mean  SD) 8.71  4.
Sleep disordered questionnaire for sleep apnea (SDQ-SA) 24.31  7
b: Caregiver characteristics
Caregive
Demographic characteristics
Age (mean  SD) 46.18  
Gender (n, % female) 33 (68.7
Race (n, % caucasian) 45 (93.7
Religion (n, % Christian) 36 (75%
Relationship to patient (n, %)
Spouse/partner 28 (58.3
Parent/sibling 18 (37.5
Other 2 (4.17%
Employment (n, % employed) 34 (70.8
Education (n, % some college and beyond) 39 (81.2
Marital status (n, % married) 38 (79.1
Cohabitation with patient (n, %) 43 (89.5
Time spent for patient care (hours) per week (mean  SD) 11.43  
SD, standard deviation; IQR, inter-quartile range; AEDs, antiepileptic drugs; EMU, epilep
idiopathic generalized epilepsy; MRI, magnetic resonance imaging; SF36v2, short form
Higher score is better for MoCA and worse for Beck depression and anxiety inventorie
a t-test.
b Chi-square test.
c Wilcoxon rank-sum test (Mann–Whitney U test).studies, PNES patients were more likely to be female (approxi-
mately 79% vs 59% in the ES cohort, p = 0.03). On the other hand, ES
patients typically had an earlier disease onset (24 vs 35 years of
age, p = 0.0005) and a longer disease duration (15 vs 7 years,
p = 0.0001). Despite experiencing more events per month (6 vs 3,
p = 0.009), PNES patients were on average on fewer AED (1 vs 2,
p = <0.0001). As expected, PNES patients had a faster posterior
dominant rhythm on their EEG (9.96 vs 9.4 Hz, p = 0.01) and fewer
EEG abnormalities (88% with a normal EEG vs 46% in the ES cohort,
p < 0.0001). Similarly, MRI was abnormal only in 36% of PNES
patients, typically due to nonspeciﬁc white matter disease, as
opposed to 69% of ES patients (p < 0.0006). In accord to existing patients N = 126 PNES patients N = 33 p Value
3.48 41.84  11.44 0.15a
3%) 26 (78.79%) 0.03b
74%) 29 (87.88%) 0.55b
 20 (64.52%) 0.25b
4%) 15 (46.88%) 0.37b
9%) 27 (87.10%) 0.18b
59%) 27 (81.82%) 0.59b
8%) 19 (57.58%) 0.07b
6.42 34.78  12.98 0.0005a
3.54 7.12  8.24 0.0001a
6 (3–25) 0.007c
1 (1–2) <0.0001c
7%) 21 (77.78%) 0.87b
1%) 15 (88.24%) 0.25b
8%) 2 (11.76%)
) 0 (0%)
13 9.96  1.17 0.01a
4%) 4 (12.12%) <0.0001b
0%) 0 (0%)
7%) 29 (87.88%)
7%) 11 (35.48%) <0.0006b
.49 25.62  3.40 0.65a
2.09 19  11.55 0.01a
3.34 22.96  17.17 0.01a
58 7.77  6.41 0.44a
.63 27.75  7.57 0.03a
rs ES N = 48 Caregivers PNES N = 18 p Value
13.20 47.44  9.67 0.71a
5%) 9 (50%) 0.15b
5%) 17 (94.44%) 0.91b
) 14 (77.78%) 0.81b
4%) 14 (77.77%) 0.13b
0%) 3 (16.66%)
) 1 (5.55%)
3%) 13 (72.22%) 0.91b
5%) 12 (66.67%) 0.20b
7%) 15 (83.33%) 0.70b
8%) 15 (83.33%) 0.48b
21.22 19.78  25.14 0.20a
sy monitoring unit; EEG, electroencephalogram; TLE, temporal lobe epilepsy; IGE,
 36 health survey.
s as well as for the Epworth sleepiness scale and the SDQ-SA.
Table 2
Comparison of QOL scores.
a: Subscores of ES vs PNES patients
Epilepsy patients N = 126 PNES patients N = 33 p Value
Quality of life characteristics (QOLIE-31)
Seizure worry 43.36  27.93 42.58  32.58 0.89a
Overall quality of life 57.90  21.62 48.95  19.89 0.03a
Emotional wellbeing 61.03  21.31 53.76  23.21 0.08a
Energy/fatigue 43.02  22.69 40.84  21.34 0.61a
Cognitive functioning 50.54  25.64 41.28  25.94 0.06a
Medication effects 44.35  28.28 44.01  30.67 0.95a
Social functioning 46.87  28.40 32.99  21.48 0.009a
Overall score 51.31 + 18.29 43.41  16.35 0.02a
b: Subscores of ES vs PNES caregivers
Caregivers ES N = 48 Caregivers PNES N = 18 p Value
Quality of life characteristics (SF36v2)
Physical component scale (PCS) (mean  SD) 53.91  8.86 51.70  8.58 0.37a
Mental component scale (MCS) (mean  SD) 45.51  11.31 41.23  12.88 0.20a
Burden characteristics
Zarit burden inventory (mean  SD) 20.02  14.47 23.27  13.53 0.41a
Higher score is better for all subscales of QOLIE-31.
Higher score is better for SF36v2 scales and worse for Zarit burden inventory.
a t-test.
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(mean BDI score 19 vs 13, p = 0.01) and anxiety (mean BAI score 23
vs 16, p = 0.01) inventories. Interestingly, a higher score was also
seen in the PNES cohort in the sleep apnea component of the SDQ
(28 vs 24, p = 0.03).
ES and PNES caregivers were comparable in all socio-
demographic categories. The majority were around 47 years of
age, Caucasians, with some college education, employed, married
and cohabitants with the patients. These ﬁndings are depicted in
Table 1b.
3.2. Comparison of QOL scores of patients with ES and PNES
Consistent with previous literature, the overall QOL score of
PNES patients was inferior to that of ES patients (43 vs 53, p = 0.02).
Certain subscales of the QOLIE-31 inventory such as overall quality
of life (p = 0.03) and social functioning (p = 0.009) also reached
statistical signiﬁcance of similar directionality, while others such
as emotional well-being (p = 0.08) and cognitive functioning
(p = 0.06) approximated statistical signiﬁcance (Table 2a).
3.3. Comparison of QOL scores of caregivers with ES and PNES
As illustrated in Table 2b, the physical component summary
score of the SF36v2 QOL questionnaire was approximately 54 for
ES caregivers and 52 for PNES caregivers. Their respective mental
component summary scores for the two cohorts were 46 and 51,Table 3
QOL determinants for patientsa.
a: QOL determinants for ES patients
Variable Beta coefﬁcient 
Patient male gender 9.29080 
Patient employed 5.68276 
Number of AEDs 5.60662 
Patient Beck anxiety inventory score 0.56245 
Patient SDQ-sleep apnea score 0.58948 
b: QOL determinants for PNES patientsb
Variable Beta coefﬁcient
Patient Beck depression inventory score 0.85819 
a Higher score is worse for Beck anxiety inventory and SDQ-SA.
b Higher score is worse for Beck depression inventory.respectively. These differences did not attain statistical signiﬁ-
cance. The Zarit burden interview score was on average 20 for ES
caregivers and 23 for PNES caregivers; again a non-signiﬁcant
statistical difference.
3.4. QOL determinants in ES and PNES patients
In the adjusted analysis (Table 3a and b), male gender (b = 9.29,
p = 0.0011), employed status (b = 5.68, p = 0.0371), smaller AED
number (b = 5.6, p = 0.0004), lower anxiety level (b = 0.56,
p < 0.0001) and lower sleep apnea complaints (b = 0.58,
p = 0.0006) were associated with higher QOL scores for the ES
patients (Adjusted R2: 0.52). On the other hand, for the PNES
population, the only determinant of better QOL was lower
depression scores (b = 0.85, p = 0.0025) (Adjusted R2 = 0.55).
3.5. QOL determinants in ES and PNES caregivers
The physical component summary (PCS) score of ES caregiver
QOL was mostly determined by the caregiver employment status
and the burden associated with patient care, with employed
caregivers (b = 5.59, p = 0.0376) with lower burden scores (b = –
0.16, p = 0.0435) enjoying a better quality of life (Adjusted R2 = 0.25).
The mental component summary (MCS) score of caregiver QOL
was better for male caregivers (b = 8.42, p = 0.0036) who cared for
less depressed patients (b = 0.32, p = 0.0418) and experienced
lower burden scores (b = 0.36, p = 0.0006) (Adjusted R2 = 0.43).Standard error p Value
2.76918 0.001
2.68688 0.03
1.51196 0.0004
0.11754 <0.0001
0.16705 0.0006
 Standard error p Value
0.25680 0.002
Table 4
QOL determinants for caregivers.
a: QOL determinants for ES caregiversa
Variable Beta coefﬁcient Standard error p Value
Quality of life-physical component score (PCS)
Caregiver employed 5.59881 2.60389 0.03
Caregiver Zarit burden interview score 0.16902 0.08107 0.04
Quality of life-mental component score (MCS)
Patient Beck depression inventory score 0.32197 0.15325 0.04
Caregiver male gender 8.42970 2.73260 0.003
Caregiver Zarit burden interview score 0.36883 0.09852 0.0006
b: QOL determinants for PNES caregiversb
Variable Pearson correlation coefﬁcient p Value
Quality of life-physical component score (PCS)
None – –
Quality of life-mental component score (MCS)
Patient posterior dominant rhythm 0.55 0.03
Caregiver age 0.49 0.04
Caregiver Zarit burden interview score 0.73 0.0009
a Higher score is worse for Zarit burden and Beck depression inventories.
b Higher score is worse for Zarit burden inventory. Multivariate analysis was limited by the modest number of available PNES caregivers.
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limited by the modest number of PNES caregivers. In the univariate
analysis, no statistically signiﬁcant predictor of PNES caregiver
QOL PCS score was identiﬁed. On the other hand, the MCS score of
PNES caregiver QOL was again dependent on the burden associated
with patient care (r = 0.73, p = 0.0009), the age of the caregiver
(r = 0.49, p = 0.04) and patient posterior dominant rhythm
(r = 0.55, p = 0.03). From those three factors, only the burden
associated with patient care (b = –0.60, p = 0.01) sustained in a
subsequent multivariate regression model (not shown).
These results are summarized in Table 4a and b.
4. Discussion
This study yields two novel ﬁndings and corroborates two
previously reported observations. The novel ﬁndings are that (i)
caregiver QOL scores in PNES are comparable to those in ES and
that (ii) they are consistently dependent on caregiver burden. The
two attested observations are that (i) that patient QOL in PNES is
worse than in ES and that (ii) they are both dependent on
psychopathology more than disease characteristics.
4.1. Patient and caregiver characteristics
Our ES and PNES populations were both remarkably similar to
previous comparison studies.12 Replicating previous literature,
patients with PNES had later disease onset5,28 and a shorter disease
duration prior to being diagnosed of approximately 7 years.29 Also,
PNES patients were more likely to be female,12,30 with higher spell
frequency5,12 and on fewer AEDs.5 They had higher levels of
depression and anxiety.5,12,31 The higher index of sleep apnea
symptomatology is intriguing and may be an outcome of the higher
body mass index in PNES patients compared to ES observed in
other studies.32 Other investigators have also shown poorer quality
of sleep in PNES than ES.33 Consistent with previous reports,5
electroencephalographic and radiological abnormalities were less
prevalent in PNES patients compared to the ES cohort, but not
negligible. Past investigations also mentioned EEG abnormalities
in about 9% of PNES patients34 and MRI abnormalities in
approximately 23–27% of patients.10 No additional differences
were seen in demographic variables, AED compliance and levels.
Mirroring previous research, no neurocognitive differences wereseen between ES and PNES patients, a ﬁnding possibly representing
poor effort during assessment.35
4.2. Comparison of QOL scores of patients with ES and PNES
Patient QOL scores have been consistently found to be lower in
PNES, irrespective whether seizure-directed (e.g. QOLIE-3112 or
QOLIE-8936) or generic questionnaires (SF3637) were applied. Our
absolute values for both populations were also similar to former
studies using the same instrument in the inpatient38 and
outpatient12 setting, in the US12 and the UK,38 advocating for
generalizability of our results.
4.3. Comparison of QOL scores of caregivers with ES and PNES
Our caregiver QOL scores are difﬁcult to compare with the
existing literature. We could only identify caregiver studies on ES
patients. Most have focused on the pediatric population. In the
adult population, the majority has been performed in the
outpatient setting and outside the US. In particular, similar to
our study, a Dutch outpatient study identiﬁed a trend of decreased
mental component of QOL in caregivers of refractory ES patients.39
In Brazil, Westphal-Guitti et al. compared 50 adolescent and adult
patients with juvenile myoclonic epilepsy (JME) and another 50
with temporal lobe epilepsy (TLE) along with their caregivers.26
Mild-moderate caregiver burden, averaging 22 for JME and 30 for
TLE in the Zarit scale was identiﬁed. For JME patients that burden
correlated with poorer emotional, social and physical domains of
the caregivers’ quality of life measured with SF-36, while for TLE
patients the emotional component was primarily affected.26
Another study of 65 patient-caregiver pairs from Hong Kong
identiﬁed below average scores on the quality of life measure
applied and severe levels of depression and anxiety in 14% and 22%
of caregivers respectively.40 In agreement with the Brazilian26 and
the Dutch studies,39 we also recognized heavier impact in the
mental component of caregiver QOL.
4.4. QOL determinants in ES and PNES patients
Depression and anxiety are the most common psychiatric
comorbidities in ES patients.41 Similar to our study, they have
been more closely associated with poorer quality of life than
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thology, we identiﬁed poorer QOL in female ES patients. That is in
accord with some literature46 but at odds with other.47 Employed
patients had higher scores, an observation made also else-
where.48,49 That comes as no surprise since employment,
independence and worries related to driving are major concerns
patients with advanced epilepsy in the Western world50 and
unemployment is one of the major contributors to epilepsy
stigma.51 We also noticed poorer QOL in ES patients on
polypharmacy, an association also reported before,49 irrespective
of the generation of AED used.52 Finally, sleep disturbance
was also a contributor to worse QOL, a statement made
in previous investigations where sleep questionnaires were
incorporated.46,53,54
Along similar lines, PNES commonly occur in the setting of
various psychiatric comorbidities, among which depression,
anxiety and personality disorders are the most prevalent.55 In
PNES patients depression has been also repeatedly related to
poorer QOL, irrespective of frequency of events12,56; a ﬁnding
reinforced by the current study.
4.5. QOL determinants in ES and PNES caregivers
Determinants of caregiver QOL in ES have been rarely sought in
the past. In the current study, we identiﬁed caregiver unemploy-
ment and higher caregiver burden as the main determinants of the
physical component summary of caregiver QOL. Higher caregiver
burden determined also poorer mental component summary
score, along with patient depression levels and female gender. In
partial agreement with our ﬁndings, caregiver self-perceived
burden of care and coping style were deemed to be more reliable
indicators of caregiver QOL,39 while no speciﬁc patient or disease
characteristic appeared to drive caregiver QOL.39 The gender
association was previously noted in a study of 257 caregivers
escorting patients to outpatient clinics in Sudan were lower QOL
scores were also found for caregivers who were children of the
patients and had lower education attainment.57 Contrary to our
ﬁndings, seizure severity and age at onset negatively correlated
with psychosocial adjustment of caregivers; on the other hand,
perceived support level had a positive impact in their well-being
and quality of life.40 The variability of potential contributors to
caregiver burden and QOL reported in the literature highlights
cultural differences, the diverse nature of epilepsy, and the
pleomorphic research methodology applied.
It is difﬁcult to consider the clinical implications of the
correlates of caregiver QOL in PNES that were found in the current
study, given the lack of previous studies on this topic. The strongest
correlation we identiﬁed was between higher caregiver burden
score and worse mental component summary score of caregiver
QOL. Family dysfunction is known to impact QOL in ES patients a
reciprocal way.58 Family dysfunction is prominent both in ES and
PNES and plays a predictive role to patient QOL.12 It is possible that
family dysfunction may be related to increased caregiver burden,
which would help to account for the association with caregiver
QOL that was found in our study. However, such a suggestion is
speculative given that lack of an objective measure of family
dysfunction.
4.6. Advantages and limitations
There are certain advantages to our study. The focus was on
adult patients, where most of the literature is sparse. They could
complete the surveys independently, which prevented potential
bias inevitably incurred by proxy-reports in the pediatric caregiver
literature.59 The participants completed their questionnaires prior
to their diagnosis was clariﬁed by spell characterization withvideo-EEG monitoring. That increased the equipoise among them
and facilitated more unbiased answers. The patients recruited
were classiﬁed reliably to ES vs PNES with inpatient video-EEG
monitoring, excluding equivocal cases. We monitored and mini-
mized factors that may have interfered with patient’s testing such
as seizures or commonly applied procedures in the EMU (e.g.,
antiepileptic medication withdrawal or sleep deprivation). Cross-
reference with medical records provided an additional checkpoint
for accuracy. The data collected were thorough and covered most
of the parameters reported to be associated with health-related
QOL in epilepsy, including para-clinical data such as AED levels, an
understudied ﬁeld previously. Contrary to previous studies
investigating family dysfunction12 that utilized the patient as
the informant, we had direct reporting of burden and QOL from the
caregiver. Thus, multiple patient- and caregiver-related factors
were taken into account when assessing QOL. Moreover, our data
were representative of both ES and PNES cohorts of patients.5,12
Finally, a comparison group of ES patients and caregivers was
available to provide direct comparison.
On the other hand, there are limitations to acknowledge. The
self-reporting nature of the study bears a risk of recall bias. Yet,
self-report scales are widely-used, cost-effective methods both for
diagnostic assessment and for outcome evaluation, albeit admit-
tedly not as exhaustive and objective as standardized cognitive and
psychiatric interviews or physiologic sleep recording procedures.
The modest sample size of caregiver participants may have
underpowered us for the detection of additional associations and
jeopardized the stability of a multiple regression analysis model,
limiting our related analysis to univariate correlations. Despite the
extensive evaluation of several variables, other patient-related
parameters (e.g. structured clinical interviews for DSM-IV axis
disorders or detailed psychiatric history for PNES patients, such as
information on personality disorders) and particularly other
caregiver-related aspects (e.g. social support, ﬁnancial informa-
tion, medical and psychiatric comorbidities, etc.) that may have
been signiﬁcant determinants of patient and caregiver QOL were
not directly addressed. They partially constitute however compo-
nents of the Zarit burden inventory used. The cross-sectional
nature of the study prevented further insight into the evolution of
these associations longitudinally as well as inference of causation.
We aspire though to gather follow up data on our participants to
examine the effect of establishing a diagnosis through long-term
video-EEG monitoring on their QOL. Not all patients were
accompanied by caregivers and not all caregivers participated in
the study, suggesting possibly that those willing to participate may
not be fully representative of the caregiver population and thus
creating a response bias. Similarly, the study population may limit
generalizability, particularly to certain PNES populations not or
under-represented in our study (e.g. children,60 veterans,61 male62
and elderly63 patients). Our participants were patients and
caregivers recruited in the EMU. While this allowed rigorous
classiﬁcation of their seizures and QOL determinants, it may have
skewed the results to a more severely afﬂicted patient-caregiver
group generating a selection bias that jeopardizes generalizability
of our ﬁndings to the community. However, our patient cohort
characteristics have been validated from previous inpatient and
outpatient studies as mentioned previously. Even if intractability
was overrepresented in our study, refractory population is
expected to be the target population that would mostly beneﬁt
from social interventions.
4.7. Signiﬁcance and future outlook
The ﬁndings of this study may have both clinical and research
repercussions. PNES is a heterogeneous disorder6,7,64,65 where
complex interactions of genetic, environmental and psychosocial
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integrating the dynamics, the needs and the impact on the family
is required.12 In clinical practice, physicians should consider
incorporating the caregiver into their assessment and treatment
plan in an effort to eventually improve the patient’s QOL. That is
corroborated by the results of a recent meta-analysis of 148 studies
examining the association between social relationships and
mortality risk showing a 50% increased likelihood of survival for
participants with better social support.66 It is particularly signiﬁcant
in PNES where families have been occasionally seen to restore the
patients’ identities as epileptics reinforcing abnormal illness
behavior and need for AED, even after an EMU diagnosis of PNES
has been established.67 Caregiver counseling and education,
evaluation and treatment of evolving caregiver psychopathology,
and tailored individualized and/or group multidisciplinary inter-
ventions to provide physical, emotional, social and ﬁnancial support
to the caregiver may allow the caregiver to proceed with life
relatively unencumbered. This may in turn translate to QOL
improvement for the patient. Previous studies on caregivers of
patients with dementia have corroborated that potential.68 Further,
advocacy groups should include caregiver feelings and needs into
their agenda and expert opinion panel reviews as well as national
clinical guidelines should further emphasize caregiver QOL as one of
the core quality measures in the evaluation and management of
PNES.69 In the research realm, the focus of investigation should
expand to incorporate the family well-being. Our ﬁndings suggest
associations that warrant further examination in future studies.
Speciﬁc QOL measures need to be created and validated for
caregivers of PNES patients and incorporated into future medication
and intervention related clinical trials, in addition to the so far
prevailing focus on freedom of spells.10 Similarly, caregiver
parameters may be incorporated to proposed research avenues
such as nonlinear methods application and international databases
development in an effort to address the heterogeneity of the PNES
population.70There is need for rigorous research in this understudied
ﬁeld and funding agencies should consider this important issue.
5. Conclusion
In addition to corroborating that patient QOL is worse in ES vs
PNES patients, we were also able to show that caregiver QOL in
PNES is comparable to that in ES. Caregiver burden emerges as a
consistent determinant of caregiver QOL both in ES and PNES.
These important and unique study ﬁndings emphasize the need for
further evaluation of the caregiver burden and quality of life in
PNES and for their consideration in future intervention trials and
research endeavors.
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Appendix. Questionnaires details
Beck anxiety13 and Beck depression14 inventory: These are 21-
item inventories that assess the presence and degree of affective,cognitive, motivational and psychomotor components. Each item is
scored 0–3 and the aggregate score is 0–63. Higher scores depict
higher levels of psychopathology (Depression: 1–10: normal, 11–16:
mild depression, 17–20: borderline depression, 21–30: moderate
depression, 31–40: severe depression, >41: extreme depression;
Anxiety: 0–21: very low anxiety, 22–35 moderate anxiety and >36
high anxiety).
Epworth sleeping scale16: This is a brief questionnaire rating the
chances that they would doze off or fall asleep when in eight different
situations commonly encountered in daily life. A score of 0–3 is given
to each situation and the aggregate score is 0–24. Higher scores are
suggestive of higher sleepiness level (a cut-off of >10 is generally
interpreted as daytime sleepiness).
Sleep disorder questionnaire-sleep apnea scale (SDQ-SA)17: A
score equal or more than 36 for men and 32 for women is considered
to have approximately 80% sensitivity and speciﬁcity for polysomno-
gram-proven sleep apnea [17].
Quality of life in epilepsy 31 (QOLIE-31)20: The 31-item self-
administered questionnaire has seven subscales: seizure worry,
overall quality of life, emotional well-being, energy/fatigue, cognitive
function, medication effects and social functioning. A score ranging
from 1–100 is obtained from each subscale with higher scores
indicating better quality of life.
Montreal cognitive assessment (MoCA)22: This test assesses
multiple cognitive functions (visuospatial/executive, naming, mem-
ory, attention, language, abstraction, delayed recall and orientation)
and an aggregate score of 0–30 is created. Higher scores are
associated with better cognitive state (a cut-off of <26 is considered
abnormal).
Zarit caregiver burden inventory24: This is a 22-item inventory
derived from the original 29-item inventory. The 22 items evaluate
the effect of disease on the caregiver’s quality of life, psychological
suffering, ﬁnancial difﬁculty, shame, guilt and difﬁculty in social and
family relationships. Scores range from 0 to 88 with higher scores
indicating higher burden (<20: little or no burden, 21–40: mild to
moderate burden, 41–60: moderate to severe burden, 61–88: severe
burden).
SF-36 generic questionnaire-version 2 (SF36v2)27: This is a generic
QOL instrument that assesses eight health concepts (physical
functioning, role limitation caused by physical problems, bodily
pain, general health perception, vitality, social functioning, role
limitation caused by emotional problems, mental health). Scores
standardized to norms and weighted averages are used to create a
summary physical component summary (PCS) and a mental
component summary (MCS) composed by the ﬁrst and last four of
the aforementioned health concepts respectively. All health dimen-
sion scores are standardized to normal by employing a linear
transformation of data originally scores on a 0–100 scale. Norm-based
scores have a mean of 50 and a standard deviation of 10 in the general
US population. Therefore, any score <50 for any health dimension and
component scale falls below the general population mean and each
point represents 1/10th of a standard deviation.
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